Japan Tobacco Inc. announced resolutions from the Board of Directors concerning the Company's new executive appointment. Newly appointed Executive Officer (Effective from July 1, 2024): Takayuki Yamaguchi as Senior Vice President, President, Pharmaceutical Business. Resigning Executive Officer (As of June 30, 2024): Muneaki Fujimoto as Senior Vice President, President, Pharmaceutical Business.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,446 JPY | +0.36% | +1.16% | +21.98% |
May. 14 | Jefferies Adjusts Japan Tobacco’s Price Target to 3,741 Yen From 3,353 Yen, Keeps at Hold | MT |
May. 10 | Japan Tobacco's Attributable Profit Up 9% in Q1 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.98% | 50.26B | |
+13.14% | 79.56B | |
-4.49% | 65.96B | |
+0.23% | 7.27B | |
-13.97% | 5.58B | |
-3.50% | 2.52B | |
-6.03% | 2.29B | |
-37.32% | 1.54B | |
-17.14% | 1.17B | |
-12.08% | 1.13B |
- Stock Market
- Equities
- 2914 Stock
- News Japan Tobacco, Inc.
- Japan Tobacco Inc. Announces Executive Changes